BLINCYTO
BLINCYTO
Approved
DIN Number
02450283
Drug Class
Human
Market Date
Mar 17, 2016
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02450283
AIG Number0157670001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FX07 BLINATUMOMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BLINATUMOMABActive
Strength: 38.5 MCG / VIAL
Monograph: BLINATUMOMAB